Endovenous Ablation Devices Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035)

The endovenous ablation devices market was valued at USD 1.12 Billion in 2025. It is poised to grow at a CAGR of 10.20% during the forecast period of 2026-2035, and reach USD 2.96 Billion by 2035. The market growth is driven by the rising prevalence of varicose veins and chronic venous insufficiency, along with growing patient preference for minimally invasive day-care procedures over traditional vein stripping surgery.

Latest News on the Endovenous Ablation Devices Market (2026)

April 2026: Radiofrequency Ablation Demonstrates Lower Pain and Complications Versus Laser

According to the Journal of Vascular Surgery, recent meta-analyses through 2026 show radiofrequency ablation delivers fewer complications, including paresthesia, burns, and ecchymosis, compared with endovenous laser ablation while maintaining 93 to 94 percent saphenous vein occlusion at one year. The findings continue reshaping clinical preference and reinforce competitive innovation across the global endovenous ablation devices market.

April 2026: InVera Medical Secures FDA Clearance for Non-Thermal Venous Treatment Device

According to the US FDA 510(k) clearance, InVera Medical received approval for its infusion device designed for the minimally invasive treatment of chronic venous disease, including varicose veins. The clearance supports the growing clinical shift toward non-thermal treatment technologies and strengthens innovation across the varicose vein treatment devices market.

March 2026: Cyanoacrylate Glue and Steam Ablation Expand Treatment Options

According to Endovascular Today, emerging non-thermal endovenous treatment options including cyanoacrylate glue ablation and steam techniques continued expanding clinical adoption in early 2026, complementing established radiofrequency and laser ablation procedures. The diversification of treatment modalities reinforces accelerating innovation, premiumization, and competitive positioning across the global endovenous ablation devices market amid rising prevalence of chronic venous insufficiency.

Key Market Trends and Insights

• By type, endovenous laser ablation devices are expected to hold a significant share in the market in the forecast period.
• By end user, the hospital segment held nearly 64% market share in the historical period.
• Based on region, North America accounted for approximately 38% share in the historical period.

Market Size and Forecast

• Market Size (2025): USD 1.12 Billion
• Projected Market Size (2035): USD 2.96 Billion
• CAGR (2026-2035): 10.20%
• Largest Market in 2025: North America

Endovenous Ablation Devices Market Overview

Endovenous ablation devices are catheter-based tools used to close diseased superficial leg veins in patients with chronic venous insufficiency and varicose veins, using laser, radiofrequency, or non-thermal energy under ultrasound guidance. The market growth is driven by ageing populations, rising obesity, and broad insurance coverage for minimally invasive vein procedures. The market was valued at USD 1.12 Billion in 2025 and is poised to grow at a CAGR of 10.20%. The growth is supported by single-use catheter platforms and adhesive-based, non-tumescent systems that improve patient comfort.

Endovenous Ablation Devices Market Growth Drivers

Rising Prevalence of Chronic Venous Insufficiency to Accelerate Market Expansion

The growing burden of chronic venous disease is the leading driver of demand for endovenous ablation devices. According to the American Venous Forum, around 25 million adults in the United States are affected by chronic venous insufficiency, with many cases progressing to varicose veins and venous ulcers. This rising patient pool, coupled with increasing adoption of minimally invasive treatment approaches and improved clinical decision support technologies, is expected to significantly propel market growth over the forecast period.

Endovenous Ablation Devices Market Trends

A key trend in the market is the advancement of minimally invasive and non-thermal ablation technologies, enhancing treatment efficiency, patient comfort, and procedural outcomes.

Increasing Advancement of Non-Thermal Catheter Technologies is Likely to Boost the Market Demand

The market is witnessing the advancement of non-thermal catheter-based technologies that improve procedural safety and patient comfort. In April 2026, InVera Medical received US FDA 510(k) clearance for its novel infusion device designed to enhance sclerosant delivery and treatment efficiency. Such innovations address limitations of traditional thermal approaches, supporting wider adoption of minimally invasive procedures and contributing significantly to overall market growth.

Endovenous Ablation Devices Market Segmentation

Market Breakup by Product Type

• Endovenous Laser Ablation Devices
• Radiofrequency Ablation Devices
• Non-Thermal Non-Tumescent Devices

Market Breakup by Indications

• Varicose Veins
• Chronic Venous Insufficiency
• Spider Veins
• Others

Market Breakup by End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Varicose Veins Segment to Witness Significant Growth by Indications

The market is segmented by indications into varicose veins, chronic venous insufficiency, spider veins, and others. Among these, the varicose veins segment is expected to lead due to its high prevalence and increasing treatment adoption. According to Jae Ho Chung et al., 2024, prevalence ranges from 1% to 73% in women and 2% to 56% in men, with Korea reporting a 5.4% annual rise in treated cases. This sustained demand is expected to strengthen segment growth over the forecast period.

Endovenous Ablation Devices Market Analysis by Region

North America is expected to dominate the market, supported by high chronic venous disease prevalence, advanced reimbursement frameworks, and a large network of office-based vein clinics. The growth is further driven by a high prevalence of chronic venous disorders, strong reimbursement frameworks, and widespread availability of advanced treatment options. Europe follows with steady growth due to increasing awareness and established healthcare systems, while the Asia Pacific is anticipated to witness rapid expansion owing to improving healthcare access and rising patient demand.

Leading Players in the Endovenous Ablation Devices Market

The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

AngioDynamics, Inc.

AngioDynamics, Inc. is a key participant in the endovenous ablation devices market, offering advanced laser-based solutions for varicose vein treatment. Its VenaCure EVLT System, including the 1470 Pro Laser and NeverTouch Fiber, delivers high vein closure rates and precise energy targeting. The company supports minimally invasive, office-based procedures, strengthening its position in thermal ablation technologies and clinical adoption.

Medtronic plc

Medtronic plc is a leading medical technology company actively involved in the endovenous ablation devices market. The company offers advanced radiofrequency ablation systems, including endovenous catheters designed for minimally invasive treatment of varicose veins. Through continuous innovation and clinical studies, Medtronic strengthens its position in vein care by improving procedural efficiency, patient outcomes, and expanding the adoption of thermal ablation techniques.

Teleflex Incorporated

Teleflex, headquartered in Wayne, Pennsylvania, supplies vascular access and interventional disposables that support endovenous ablation procedures, including introducer sheaths and ultrasound-guided access kits. The company maintains a footprint across more than 150 countries and continues investing in single-use procedure-pack solutions for office-based vein clinics globally.

Sciton Inc.

Sciton, headquartered in Palo Alto, California, supplies the ProV laser platform used in endovenous laser ablation procedures for varicose vein treatment. The company focuses on dermatology and aesthetic vascular applications, supplying clinics across more than 80 countries, and continues investing in modular, multi-wavelength laser systems for vein specialists.

Other key players in the market are Merit Medical Systems, Inc., Venclose, Inc., Biolitec® Holding GmbH & Co. KG, Eufoton S.r.l., RF Medical Co., Ltd., and Boston Scientific Corporation.

Key Questions Answered in the Endovenous Ablation Devices Market Report

• What was the endovenous ablation devices market value in 2025?
• What is the endovenous ablation devices market forecast outlook for 2026-2035?
• What major factors aid the demand for the endovenous ablation devices market?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major endovenous ablation devices market trends?
• Which product type is expected to dominate the market segment?
• Which indications are projected to lead the market segment?
• Which end user is anticipated to lead the global endovenous ablation devices market?
• Who are the key players in the endovenous ablation devices market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?